Mouse Anti-ARHGAP42 Recombinant Antibody (CBT3338) (V2LY-0625-LY625)

Li, Q., Dibus, M., Casey, A., Yee, C. S., Vargas, S. O., Luo, S., ... & Agrawal, P. B. (2021). A homozygous stop-gain variant in ARHGAP42 is associated with childhood interstitial lung disease, systemic hypertension, and immunological findings. PLoS genetics, 17(7), e1009639.

Mangum, K. D., Freeman, E. J., Magin, J. C., Taylor, J. M., & Mack, C. P. (2020). Transcriptional and posttranscriptional regulation of the SMC-selective blood pressure-associated gene, ARHGAP42. American Journal of Physiology-Heart and Circulatory Physiology, 318(2), H413-H424.

Fjorder, A. S., Rasmussen, M. B., Mehrjouy, M. M., Nazaryan-Petersen, L., Hansen, C., Bak, M., ... & Bache, I. (2019). Haploinsufficiency of ARHGAP42 is associated with hypertension. European Journal of Human Genetics, 27(8), 1296-1303.

Hu, Q., Lin, X., Ding, L., Zeng, Y., Pang, D., Ouyang, N., ... & Yao, H. (2018). ARHGAP 42 promotes cell migration and invasion involving PI 3K/Akt signaling pathway in nasopharyngeal carcinoma. Cancer medicine, 7(8), 3862-3874.

Luo, W., Janoštiak, R., Tolde, O., Ryzhova, L. M., Koudelková, L., Dibus, M., ... & Rosel, D. (2017). ARHGAP42 is activated by Src-mediated tyrosine phosphorylation to promote cell motility. Journal of cell science, 130(14), 2382-2393.

Bai, X., Mangum, K. D., Dee, R. A., Stouffer, G. A., Lee, C. R., Oni-Orisan, A., ... & Mack, C. P. (2017). Blood pressure–associated polymorphism controls ARHGAP42 expression via serum response factor DNA binding. The Journal of clinical investigation, 127(2), 670-680.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols